{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:51:50Z","timestamp":1795085510874,"version":"4.10.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH122196"],"award-info":[{"award-number":["R01 MH122196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 DA045825"],"award-info":[{"award-number":["R21 DA045825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005497","name":"American Society for Pharmacology and Experimental Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008209","name":"University at Buffalo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neuropharm.2023.109743","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:22:05Z","timestamp":1696832525000},"page":"109743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats"],"prefix":"10.1016","volume":"241","author":[{"given":"Yuanli","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-5783","authenticated-orcid":false,"given":"Alaina","family":"Wojciechowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4202-5719","authenticated-orcid":false,"given":"Robert","family":"Ettaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaliana","family":"Veros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8230-4144","authenticated-orcid":false,"given":"Morgan","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5731-580X","authenticated-orcid":false,"given":"Paula","family":"Carvalho Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6512-9179","authenticated-orcid":false,"given":"Jacob","family":"DiStasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-2662","authenticated-orcid":false,"given":"Jennifer J.","family":"Peirick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Reissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-2728","authenticated-orcid":false,"given":"Stewart D.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109743_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035538","article-title":"Mouse estrous cycle identification tool and images","volume":"7","author":"Byers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109743_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070800","article-title":"A role for neuropeptide S in alcohol and cocaine seeking","volume":"15","author":"Cannella","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2023.109743_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pneurobio.2012.09.005","article-title":"The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin\/orexin neurotransmission","volume":"100","author":"Cannella","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2011.02.009","article-title":"Intraventricular administration of neuropeptide S has reward-like effects","volume":"658","author":"Cao","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12971","article-title":"Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid","volume":"26","author":"Chou","year":"2021","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.peptides.2010.10.018","article-title":"Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat","volume":"32","author":"Cifani","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2023.109743_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2017.03.001","article-title":"Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation","volume":"118","author":"Clark","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109743_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(86)90466-8","article-title":"Hyperphagic and anorectic effects of \u00df-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam","volume":"120","author":"Cooper","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060219","article-title":"Identification of a role for the ventral hippocampus in neuropeptide S-elicited anxiolysis","volume":"8","author":"Dine","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109743_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1113\/jphysiol.1970.sp009220","article-title":"Drinking induced by injection of angiotensin into the rain of the rat","volume":"210","author":"Epstein","year":"1970","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117319","article-title":"Neuronal expression of the human neuropeptide S receptor NPSR1 identifies NPS-induced calcium signaling pathways","volume":"10","author":"Erdmann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109743_bib12","series-title":"Inferential Statistics and Probability - A Holistic Approach","author":"Geraghty","year":"2022"},{"key":"10.1016\/j.neuropharm.2023.109743_bib13","doi-asserted-by":"crossref","first-page":"12214","DOI":"10.1523\/JNEUROSCI.2161-17.2017","article-title":"Neuropeptide S activates paraventricular oxytocin neurons to induce anxiolysis","volume":"37","author":"Grund","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109743_bib14","article-title":"Neuropeptide S induces acute anxiolysis by phospholipase C-dependent signaling within the medial amygdala","author":"Grund","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"39","key":"10.1016\/j.neuropharm.2023.109743_bib15","first-page":"1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","volume":"21","author":"Guyenet","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2023.109743_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuropharm.2013.02.002","article-title":"Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Abeta(1)(-)(4)(2) in mice novel object and object location recognition tasks","volume":"70","author":"Han","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109743_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/npp.2011.317","article-title":"Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons","volume":"37","author":"Ionescu","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109743_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.npep.2017.11.004","article-title":"The ventromedial hypothalamic nucleus plays an important role in anxiolytic-like effect of neuropeptide S","volume":"67","author":"Jiang","year":"2018","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2023.109743_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuron.2008.07.002","article-title":"Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala","volume":"59","author":"Jungling","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109743_bib20","doi-asserted-by":"crossref","first-page":"19567","DOI":"10.1073\/pnas.1004100107","article-title":"Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system","volume":"107","author":"Kallupi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2023.109743_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-012-2910-y","article-title":"Hypothalamic neuropeptide S receptor blockade decreases discriminative cue-induced reinstatement of cocaine seeking in the rat","volume":"226","author":"Kallupi","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109743_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.peptides.2015.07.024","article-title":"Neuropeptide S Increases locomotion activity through corticotropin-releasing factor receptor 1 in substantia nigra of mice","volume":"71","author":"Li","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2023.109743_bib23","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/cne.22603","article-title":"Molecular fingerprint of neuropeptide S-producing neurons in the mouse brain","volume":"519","author":"Liu","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2011.08.016","article-title":"Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects","volume":"62","author":"Lukas","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109743_bib25","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.peptides.2010.02.006","article-title":"Microinjection of neuropeptide S into the rat ventral tegmental area induces hyperactivity and increases extracellular levels of dopamine metabolites in the nucleus accumbens shell","volume":"31","author":"Mochizuki","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2023.109743_bib26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.peptides.2010.02.006","article-title":"Microinjection of neuropeptide S into the rat ventral tegmental area induces hyperactivity and increases extracellular levels of dopamine metabolites in the nucleus accumbens shell","volume":"31","author":"Mochizuki","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2023.109743_bib27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/npp.2010.207","article-title":"Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain","volume":"36","author":"Okamura","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109743_bib28","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.neuropharm.2023.109743_bib29","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1124\/jpet.105.093427","article-title":"Pharmacological characterization of human and murine neuropeptide s receptor variants","volume":"315","author":"Reinscheid","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109743_bib30","series-title":"Novel G Protein-Coupled Receptor Protein and DNA Thereof","author":"Sato","year":"2004"},{"key":"10.1016\/j.neuropharm.2023.109743_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pbb.2012.09.003","article-title":"Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats","volume":"103","author":"Schmoutz","year":"2012","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109743_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2010.06947.x","article-title":"Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex","volume":"115","author":"Si","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109743_bib33","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109743_bib34","first-page":"1","article-title":"Food and drug reward: overlapping circuits in human obesity and addiction","author":"Volkow","year":"2011","journal-title":"Brain Imag. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109743_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1461145711000678","article-title":"Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression","volume":"15","author":"Wegener","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cne.21159","article-title":"Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain","volume":"500","author":"Xu","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109743_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuron.2004.08.005","article-title":"Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects","volume":"43","author":"Xu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109743_bib38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/ph14101024","article-title":"Identification of a novel neuropeptide S receptor antagonist scaffold based on the SHA-68 core","volume":"14","author":"Zarkin","year":"2021","journal-title":"Pharmaceuticals"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:27:03Z","timestamp":1758439623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823003337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"alternative-id":["S0028390823003337"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109743","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109743"}}